Instructions for Pulmicort Turbuhaler (Budesonide) powder
English product name
Pulmicort Turbuhaler
Release form Pulmicort Turbuhaler
powder d/ingal. dosage 100 ug/1 dose: turbuchaler 200 doses
powder d/ingal. dosage 200 ug/1 dose: 100 or 200 doses
Description:
Inhalation powder dosed in the form of round granules in white to almost white, easily destructible at the slightest mechanical action; A small part may be present as powder.
1 dose
besonide 200 mg
100 doses - plastic inhalers (1) consisting of a metering device, a powder storage tank, a desiccant tank, a mouthpiece and covers - cardboard packs.
200 doses - plastic inhalers (1) consisting of a metering device, a powder storage tank, a desiccant tank, a mouthpiece and covers - cardboard packs.
ATC codes
R03BA02 Budesonide
Clinical-pharmacological groups / Group affiliation
GCS for inhalations
Active substance
besonide
Pharmacotherapy group Pulmicort Turbuhaler:
Glucocorticosteroid for local use
Storage Conditions
Store at temperatures below 30°C, in a place not accessible to children.
Best before date
The shelf life is two years.
Testimony Pulmicort Turbuhaler:
- bronchial asthma,
- requiring supportive therapy with glucocorticosteroids to control the inflammatory process.
- chronic obstructive pulmonary disease (COPD).
Method of use, course and dosage:
The dose of Pulmicort Turbuhaler is selected individually. Recommended doses of the drug in case of inhalation glucocorticosteroid therapy during severe exacerbations of bronchial asthma, as well as against the background of lowering of the dose or withdrawal of oral GCS, are as follows:
Children older than six years: 100-800 ug/day (total daily house of the drug can be divided into two - four inhalations). If the recommended dose does not exceed 400 ug/day, the entire dose of the drug can be taken at one time (at once).
In children, the transition to a single dose of the drug should be supervised by a pediatrician.
Adults: the usual dose is 200-800 μg/day (the total daily dose of the drug can be divided into two or four inhalations). For the treatment of severe acute bronchial asthma, the daily dose can be increased to 1600 μg. In case the recommended dose does not exceed 400 μg/day, the whole dose of the drug can be crushed at one time (at once).
- Nosology Pulmicort Turbuhaler (ICD codes)
- J44
- Other chronic obstructive pulmonary disease
- J45
- Astma
Pharmacological effect Pulmicort Turbuhaler:
Glucocorticosteroid for local use.
Budesonide is a glucocorticosteroid with a strong local anti-inflammatory effect.
The exact mechanism of action of glucocorticosteroids in the treatment of bronchial asthma is not completely clear. Anti-inflammatory effects, such as inhibition of the release of inflammatory mediators and cytokine-mediated immune responses, are perhaps most important. Budesonide's affinity for glucocorticosteroid receptors is fifteen times higher than that of prednisone.
